Search results for "Heart failure"


 
Results 71 - 80 of about 462 for "Heart failure".
Sort by: Relevance | Newest | Oldest

MKSAP Quiz: 3-year history of palpitations, fatigue

A 42-year-old woman is evaluated for a 3-year history of palpitations and fatigue. She reports no chest pain, dizziness, near-syncope, or syncope. Ambulatory 24-hour electrocardiographic monitoring shows frequent monomorphic premature ventricular contractions (22% of all beats) and frequent ventricular bigeminy. What is the most appropriate management?
https://immattersacp.org/archives/2021/06/mksap-quiz-3-year-history-of-palpitations-fatigue.htm
1 Jun 2021

Closing care gaps in adult congenital heart disease

Many patients who are congenital heart disease survivors face gaps as they transition out of pediatric care, leading to problems that might have been avoided had they received appropriate, continuous care.
https://immattersacp.org/archives/2020/03/closing-care-gaps-in-adult-congenital-heart-disease.htm
1 Mar 2020

Low-dose aspirin not associated with improved outcomes in heart failure without afib

A total of 5,450 patients were using low-dose aspirin at baseline, and of these, 3,840 were propensity-matched to nonaspirin users in a 1:1 ratio.
https://immattersacp.org/weekly/archives/2018/02/06/5.htm
6 Feb 2018

FDA approves heart failure drug, looks into antiseptic safety

This update covers a warning that sodium-glucose cotransporter-2 inhibitors can cause ketoacidosis, and approval of a drug that can reduce hospitalizations from worsening chronic heart failure.
https://immattersacp.org/archives/2015/07/fda.htm
1 Jul 2015

Guideline updated to include new drugs for stage C heart failure with reduced ejection fraction

Among other recommendations, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, or an angiotensin receptor-neprilysin inhibitor, along with a beta-blocker and an aldosterone antagonist, is the new recommended therapy to reduce morbidity and mortality in patients with chronic symptomatic heart failure with reduced ejection fraction.
https://immattersacp.org/weekly/archives/2016/05/24/2.htm
24 May 2016

Work toward equity in Black men's health

An expert discusses causes and effects of health disparities as well as ways to incorporate health equity into the practice of medicine.
https://immattersacp.org/archives/2023/07/work-toward-equity-in-black-mens-health.htm
1 Jul 2023

Aspirin does not appear to increase heart failure events in patients with reduced ejection fraction

No difference was seen between aspirin-treated and warfarin-treated patients for time to any first heart failure event or to first heart failure hospitalization.
https://immattersacp.org/weekly/archives/2017/08/08/4.htm
8 Aug 2017

Rosuvastatin, atorvastatin compared on effectiveness, safety in industry-funded trial

Analysis of a randomized trial in South Korea found that patients randomized to rosuvastatin developed type 2 diabetes requiring medication at a rate of 7.2%, compared to 5.3% among those given atorvastatin.
https://immattersacp.org/weekly/archives/2023/10/24/4.htm
24 Oct 2023

How to handle uncertainty

Studies have yet to tease out how physicians' tolerance of uncertainty affects their behavior and decision making, and even their sense of burnout.
https://immattersacp.org/archives/2023/02/how-to-handle-uncertainty.htm
1 Feb 2023

MKSAP Quiz: Exacerbations of heart failure

A 68-year-old man is evaluated at a follow-up appointment. He has a 7-year history of heart failure secondary to ischemic cardiomyopathy. Over the past 6 months, he has had three hospitalizations for exacerbations of his heart failure. He currently has exertional dyspnea while getting dressed, and his maximal activity level is limited to riding to the store with his wife but staying in the car. Following a physical exam and lab studies, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2018/03/13/3.htm
13 Mar 2018

Result Page: Prev   3   4   5   6   7   8   9   10   11   12   Next